Jung, K <br/><br/>
Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer.  [electronic resource] 

 -  Clinical chemistry  Nov 2001 
 - 2061-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9147 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--blood<br/>Bone Neoplasms--diagnosis<br/>Glycoproteins--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Osteoprotegerin<br/>Prostatic Neoplasms--pathology<br/>Receptors, Cytoplasmic and Nuclear--blood<br/>Receptors, Tumor Necrosis Factor